Results 31 to 40 of about 17,216 (186)

Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis

open access: yesRheumatology, 2016
Systemic onset juvenile idiopathic arthritis (sJIA) is defined as arthritis affecting one or more joint usually in the juvenile age group (< 16 years of age) with or preceded by fever of at least 2 weeks duration that is documented to be daily ...
Deepak Jain   +4 more
doaj   +1 more source

CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN

open access: yesВопросы современной педиатрии, 2014
The article describes international multicenter controlled studies of efficacy and safety of monoclonal antibodies towards interleukin 1β — kanakinumab — when treating cryopyrin-associated periodic syndrome and systemic juvenile idiopathic arthritis in ...
Ye. I. Alekseeva, R. V. Denisova
doaj   +1 more source

Pulmonary involvement in brucellosis: A case report and literature review

open access: yesClinical Case Reports, 2021
Although pulmonary involvement is rare in brucellosis it should be considered as a causative agent in patients with prolonged fever and arthritis. Also, it should be presented with manifestations resembling systemic juvenile idiopathic arthritis.
Maryam Abdollahi   +3 more
doaj   +1 more source

Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease

open access: yesSwiss Medical Weekly, 2012
Systemic-onset juvenile idiopathic arthritis (SoJIA), sometimes called Still’s disease, is a systemic inflammatory disease classified within the spectrum of juvenile idiopathic arthritis (JIA).
Rolando Cimaz   +2 more
doaj   +1 more source

Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019

open access: yesPediatric Rheumatology Online Journal, 2020
For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arthritis (SJIA) are now increasingly diagnosed ...
Scott W. Canna   +12 more
doaj   +1 more source

Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? [PDF]

open access: yesRheumatology, 2005
'Science is the systematic classification of experience' George Henry Lewes (1817-78), English philosopher, critic, dramatist, scientist. Juvenile idiopathic arthritis (JIA) is prevalent in about 1 in 1000 children. The earliest formal description of this disease was by Sir George Frederick Still in 1897.
Ramanan, AV, Grom, AA
openaire   +3 more sources

Systemic juvenile idiopathic arthritis complicated by hemophagocytic syndrome

open access: yesКлинический разбор в общей медицине
Systemic juvenile idiopathic arthritis is a polygenic autoinflammatory disease. Pronounced systemic clinical manifestations, a significant increase in the level of inflammatory markers and the absence of autoantibodies distinguish this disease from other
Natalya A. Belykh   +4 more
doaj   +1 more source

Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis [PDF]

open access: yesThe Journal of Rheumatology, 2019
Objective.To seek predictors of therapeutic response to the interleukin (IL)-1 inhibitor anakinra in children with systemic-onset juvenile idiopathic arthritis (sJIA).Methods.The clinical charts of all patients with sJIA who were newly treated with anakinra at our center between 2004 and 2017 were reviewed retrospectively.
Benedetta Saccomanno   +9 more
openaire   +3 more sources

Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis

open access: yesCase Reports in Pediatrics, 2017
Macrophage activation syndrome, a severe complication of systemic juvenile idiopathic arthritis and other inflammatory diseases, represents one of the most important rheumatological emergencies.
Kenan Barut   +4 more
doaj   +1 more source

Clinical Case of Tocilizumab Use in a Patient with Systemic Juvenile Idiopathic Arthritis

open access: yesПедиатрическая фармакология, 2016
The article presents a case of using genetically engineered biopharmaceutical tocilizumab in a child with systemic juvenile idiopathic arthritis. On the initial stage, the treatment was characterized by resistance to high doses of glucocorticoids and ...
Y. M. Spivakovskiy   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy